Literature DB >> 11367845

[Contrast-enhanced three-dimensional MR angiography of the carotid artery at 1.0 Tesla compared to i.a. DSA: is the method suitable for the diagnosis of carotid stenosis?].

K Oberholzer1, K F Kreitner, P Kalden, M Pitton, M Requardt, M Thelen.   

Abstract

PURPOSE: To evaluate the efficacy of three-dimensional, contrast-enhanced magnetic resonance angiography (CE-MRA) of the carotid artery with a 1.0 T system in comparison to intra-arterial conventional angiography (i.a.CA) for the assessment of carotid artery disease.
METHOD: 55 patients with suspected stenosis of the carotid artery were examined with a 3 D-CE gradient-echo sequence on a 1.0 T scanner (TR/TE = 6.2/2.2 ms) and a selective DSA i.a. angiography. Image quality was evaluated by estimating the arterial contrast and venous enhancement. Morphological pathologies were registered for all arteries, stenoses of the internal carotid artery were graded by applying the NASCET criteria.
RESULTS: Sensitivity and specificity of MRA in detecting high-grade stenosis (> or = 70%) and occlusion of the extracranial internal carotid artery were 97.7 and 94.0%. Therapeutic relevant misinterpretations were mostly based on overestimating the stenoses.
CONCLUSION: The applied CE-MRA technique with a 1.0 T system is suitable for the assessment of carotid artery stenoses. In case of a therapeutically relevant stenosis revealed by MRA, however, verification of the diagnosis by i.a. CA is recommended.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11367845     DOI: 10.1055/s-2001-12476

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

1.  Dose optimization of contrast-enhanced carotid MR angiography.

Authors:  M Unterweger; J M Froehlich; R A Kubik-Huch; B Seifert; M Birrer; T Huber; R Otto
Journal:  Eur Radiol       Date:  2005-05-05       Impact factor: 5.315

2.  Diagnostic accuracy of contrast-enhanced MR angiography in severe carotid stenosis: meta-analysis with metaregression of different techniques.

Authors:  Jan Menke
Journal:  Eur Radiol       Date:  2009-04-28       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.